global-public-health-2019-scientifictracks

2 / 5

Notes:
Page 29
March 25-26, 2019 | Amsterdam, Netherlands
2 nd Global Public Health Congress
Journal of Community Medicine & Health Education | ISSN : 2161-0711 Volume 09 Global Public Health 2019
Nigerian antimicrobial consumption surveillance
Introduction: Community consumption of antibiotics is a driver for resistance. This report
provides update on the Antimicrobial Consumption Surveillance (AMCS) in Nigeria.
Methods: Community consumption of antibiotics were collected from 16 states using the
WHO ATC/DDD methodology and reported as defined daily doses per 1000 inhabitants
per day (DID). Validated data from week 29, 2017 to week 45, 2018 were analyzed.
Result: Total antibiotic consumption increased from 0.007 DDD/1000 inhabitants/days in
2017 to 0.086DDD/1000 inhabitants/days in 2018. In 2017, Penicillin (ATC group J01C)
was the most frequently used antibacterial, accounting for 64% of total sales. Amoxicillin
in particular was 37% of all J01 antibiotic sold over the counter, followed by imidazole
derivative metronidazole (ATC group J01XD) at 12%. Oral antibiotic accounted for 96%
mean route of administration in 2017 and 2018. In comparison, the ratio of sales of the
broad spectrum to the narrow spectrum antibiotics dropped by 92% in 2018, however
increased percentage use of cephalosporins, macrolides and quinolones was observed.
Discussion: There is prevalent use of penicillin increasing the likelihood for resistance.
The European center for disease control and prevention, reported a similar picture with
penicillin as the most frequently dispensed in countries such as Germany and Slovenia
making 36% and 71% of total consumption respectively. Prudent use of antimicrobials
especially penicillin should take precedence for stronger antimicrobial stewardship
measures. Penicillin-resistant Enterococci and methicillin resistant Staphylococcus
aureus (MRSA) are serious penicillin resistant infections that occur often due to selective
pressure on penicillin.
Biography
HelenAdamu is an Epidemiologist and the focal person inAntimicrobial Consumption Surveillance representing
her organization with the Nigerian Center for Disease Control. Her work created new interest in antimicrobial
use surveillance for improved surveillance system. She is an avid Researcher with seven papers published in
reputable journals.
Helen Adamu et al., J Community Med Health Educ 2019, Volume 09
DOI: 10.4172/2161-0711-C2-056
Helen Adamu
1Centre for Clinical Care and Research, Nigeria
CO-Authors
Chinelo Egwu 2, 3 and Winifred Ukponu 2
2University of Baltimore Maryland, Plot 784, USA
3Gilmore Engineering, Nigeria